Pfizer's
Centers for Therapeutic Innovation (CTI) offer
a unique collaboration opportunity for leading academic centres to partner
with Pfizer and
rapidly translate novel innovations into new medicines.
CTI collaborations
may include:
· funded
project-related research
· hands-on
partnering from dedicated Pfizer drug-development
experts
· collaborative
use of Pfizer's
science and technologies
· financial
incentives in the form of milestone and royalty payments for successful program
· flexible
publishing rights
· involvement
of CTI's
Foundation alliances
A non-confidential
two-page overview of the target, mechanism of action, evidence for disease
linkage, and the proposed therapeutic drug, is to be submitted to the Faculty
Business Development team by Friday 2 November 2018 via email to mnhs.busdev@monash.edu.More information HERE.
No comments:
Post a Comment